Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Kerr

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|February 8, 2003
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trialDavid J Kerr, Colin S McArdle, Jonathan Ledermann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 22, 2005
EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunitiesPatrick Couvreur, Diane Barguer, Daan J A Crommelin, et al.
International Journal of Cancer|December 18, 2019
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancerElin Ersvaer, Tarjei S Hveem, Ljiljana Vlatkovic, et al.
Lancet (London, England)|February 17, 2009
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trialAnnie M Young, Lucinda J Billingham, Gulnaz Begum, et al.
Anticancer Research|March 10, 2015
Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trialMegan J McGregor, Wakkas Fadhil, Rose Wharton, et al.
Hepatology (Baltimore, Md.)|November 5, 2008
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinomaDaniel H Palmer, Rachel S Midgley, Noweeda Mirza, et al.
Clinical Colorectal Cancer|July 2, 2013
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT databaseWinson Y Cheung, Qian Shi, Michael O'Connell, et al.
The New England Journal of Medicine|July 27, 2007
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancerDavid J Kerr, Janet A Dunn, Michael J Langman, et al.
Molecular Cancer Research : MCR|January 3, 2025
Coevolution of Atypical BRAF and KRAS Mutations in Colorectal TumorigenesisConnor E Woolley, Enric Domingo, Juan Fernandez-Tajes, et al.
International Journal of Cancer|April 25, 2022
Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndromeKatie Watts, Christopher Wills, Ayman Madi, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|February 8, 2003
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trialDavid J Kerr, Colin S McArdle, Jonathan Ledermann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 22, 2005
EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunitiesPatrick Couvreur, Diane Barguer, Daan J A Crommelin, et al.
International Journal of Cancer|December 18, 2019
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancerElin Ersvaer, Tarjei S Hveem, Ljiljana Vlatkovic, et al.
Lancet (London, England)|February 17, 2009
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trialAnnie M Young, Lucinda J Billingham, Gulnaz Begum, et al.
Anticancer Research|March 10, 2015
Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trialMegan J McGregor, Wakkas Fadhil, Rose Wharton, et al.
Hepatology (Baltimore, Md.)|November 5, 2008
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinomaDaniel H Palmer, Rachel S Midgley, Noweeda Mirza, et al.
Clinical Colorectal Cancer|July 2, 2013
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT databaseWinson Y Cheung, Qian Shi, Michael O'Connell, et al.
The New England Journal of Medicine|July 27, 2007
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancerDavid J Kerr, Janet A Dunn, Michael J Langman, et al.
Molecular Cancer Research : MCR|January 3, 2025
Coevolution of Atypical BRAF and KRAS Mutations in Colorectal TumorigenesisConnor E Woolley, Enric Domingo, Juan Fernandez-Tajes, et al.
International Journal of Cancer|April 25, 2022
Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndromeKatie Watts, Christopher Wills, Ayman Madi, et al.
Pageof 12